Home | 2017 | October | 13 | H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant awarded
H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant awarded
NewsComments Off on H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant awarded
H2020 Marie Sklodowska-Curie Innovative Training Networks (ITN) grant awarded to a consortium of 15 European groups and SMEs. The consortium includes 9 Transautophagy participants (Anaxomics, Patrcia Boya, Patrice Codogno, Eeva-Liisa Eskelinen, Heinz Jungbluth, Caludine Kraft, Tassula Proikas-Cezanne, Fulvio Reggiori, Anne Simonsen) and will closely collaborate with Transautophagy through the reciprocal advertisement of activities.
The manipulation of autophagy has an enormous therapeutic potential to revolutionize the way we currently treat cancers, neurodegenerative disorders, inflammatory and infectious diseases. Despite the great promises made by pioneering medical studies, the still limited applied research on autophagy has hampered the translation of fundamental knowledge into clinical-grade products and improved healthcare. Applied autophagy research is essential to understand the roles of autophagy in the different physiological and pathological situations, to generate (disease) models and develop biomarkers and assays to assess its progress.
The goal of the ITN Driving next generation autophagy researchers towards translation (DRIVE) is to train young scientists to fill this gap. DRIVE will equip its ESRs with an unique combination of knowledge and experimental expertise that are brought together in this consortium by the different partners. The realization of their projects in applied autophagy research will benefit of an exceptional interdisciplinary platform integrating cell biology, biochemistry, molecular biology, genetics, chemistry and “omics” approaches. In addition, DRIVE ESRs will acquire competencies to exploit the results for the development of products and techniques of commercial value. These ESRs will also be trained in disseminating results and knowledge through modern channels of communication.
DRIVE will, therefore, create a new generation of autophagy researchers trained in both academic and industrial settings, with the skills required to accelerate the integration of fundamental knowledge into translation. They will also have increased career perspectives and will put Europe in the lead for the exploitation of autophagy therapy for the benefit of public healthcare.
COST (European Cooperation in Science and Technology) is a pan-European intergovernmental framework. Its mission is to enable break-through scientific and technological developments leading to new concepts and products and thereby contribute to strengthening Europe’s research and innovation capacities. www.cost.eu
COST is supported by EU Framework Programme Horizon 2020.
TRANSAUTOPHAGY COST ACTION
Neuroscience Institute, Faculty of Medicine Universitat Autónoma de Barcelona